Disc Medicine undergoes restructuring plan; slashes 20% of workforce
Source: SeekingAlpha
2026-02-27 17:28:08 ET
More on Disc Medicine
- Disc Medicine: Downgrading As CRL Puts APOLLO Study Into Question
- Disc Medicine, Inc. (IRON) Discusses FDA Complete Response Letter and Path Forward for Bitopertin Regulatory Approval Transcript
- Disc Medicine After The CRL: Risk Now Rests On APOLLO
- Disc Medicine GAAP EPS of -$6.01
- Disc Medicine plunges on FDA Complete Response Letter for bitopertin
Read the full article on Seeking Alpha
For further details see:
Disc Medicine undergoes restructuring plan; slashes 20% of workforce
Disc Medicine Inc.
NASDAQ: IRON
IRON Trading
-2.4% G/L:
$59.34 Last:
105,695 Volume:
$60.54 Open:
IRON Latest News
March 04, 2026 01:26:00 pm
Securities Investigation: Levi & Korsinsky Investigates Disc Medicine, Inc. (IRON) on Behalf of Investors
February 26, 2026 08:30:00 am
Disc Medicine Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
IRON Stock Data
$2,821,824,610
32,299,039
0.06%
62
N/A
Biotechnology & Life Sciences
Healthcare
US
Watertown
